Generalized Pairwise Comparisons (GPC): An innovative statistical methodology.
How Generalized Pairwise Comparisons Can Help Reduce Sample Size in Clinical Trials
GPC – A Novel Statistical Method for Outcome Analysis and Reporting of Prioritized Composite Endpoints
Supporting Shared Decision-Making and Communication in Breast Cancer: The ShareView Project
The key pharmaceutical trends from 2023 according to industry leaders
PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials
Trendspotting: What’s Coming for Clinical Trials and Research in 2024
One2Treat launches original treatment-decision approach to clinical research
Observing emerging trends an reshaping approaches to R&D
How One2Treat is incorporating patient perspectives in clinical trials
Embracing patient-centricity: key takeaways from the SCT-2024 annual meeting
Challenges in Oncology Trials: Analyzing Endpoints
Drug Development Trends Shaping Clinical Trials in the CRO Sector
Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access
Vox Pop Pharma – where will AI take the industry in the next five years?